Alaunos Therapeutics, Inc. Quarterly Return On Assets in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Alaunos Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q2 2024.
  • Alaunos Therapeutics, Inc. Return On Assets for the quarter ending June 30, 2024 was -199 %, a 182% decline year-over-year.
  • Alaunos Therapeutics, Inc. annual Return On Assets for 2023 was -135 %, a 160% decline from 2022.
  • Alaunos Therapeutics, Inc. annual Return On Assets for 2022 was -51.8 %, a 27% increase from 2021.
  • Alaunos Therapeutics, Inc. annual Return On Assets for 2021 was -71 %, a 53.6% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -199 -129 -182% Apr 1, 2024 Jun 30, 2024
Q1 2024 -174 -114 -191% Jan 1, 2024 Mar 31, 2024
Q4 2023 -135 -83 -160% Oct 1, 2023 Dec 31, 2023
Q3 2023 -90.6 -40.3 -80.2% Jul 1, 2023 Sep 30, 2023
Q2 2023 -70.5 -11.5 -19.5% Apr 1, 2023 Jun 30, 2023
Q1 2023 -59.6 +7.29 +10.9% Jan 1, 2023 Mar 31, 2023
Q4 2022 -51.8 +19.1 +27% Oct 1, 2022 Dec 31, 2022
Q3 2022 -50.3 +22.2 +30.6% Jul 1, 2022 Sep 30, 2022
Q2 2022 -59 +4.76 +7.46% Apr 1, 2022 Jun 30, 2022
Q1 2022 -66.9 -13.4 -25.1% Jan 1, 2022 Mar 31, 2022
Q4 2021 -71 -24.8 -53.6% Oct 1, 2021 Dec 31, 2021
Q3 2021 -72.5 -27.9 -62.6% Jul 1, 2021 Sep 30, 2021
Q2 2021 -63.8 +19.7 +23.5% Apr 1, 2021 Jun 30, 2021
Q1 2021 -53.5 +44.9 +45.6% Jan 1, 2021 Mar 31, 2021
Q4 2020 -46.2 +76.6 +62.4% Oct 1, 2020 Dec 31, 2020
Q3 2020 -44.6 -145 -145% Jul 1, 2020 Sep 30, 2020
Q2 2020 -83.4 -269 -145% Apr 1, 2020 Jun 30, 2020
Q1 2020 -98.4 -279 -155% Jan 1, 2020 Mar 31, 2020
Q4 2019 -123 -291 -173% Oct 1, 2019 Dec 31, 2019
Q3 2019 100 +190 Jul 1, 2019 Sep 30, 2019
Q2 2019 186 +263 Apr 1, 2019 Jun 30, 2019
Q1 2019 180 +249 Jan 1, 2019 Mar 31, 2019
Q4 2018 169 +235 Oct 1, 2018 Dec 31, 2018
Q3 2018 -89.9 -27.1 -43.1% Jul 1, 2018 Sep 30, 2018
Q2 2018 -77.2 -17.3 -28.9% Apr 1, 2018 Jun 30, 2018
Q1 2018 -68.5 +93 +57.6% Jan 1, 2018 Mar 31, 2018
Q4 2017 -66.1 +73.8 +52.8% Oct 1, 2017 Dec 31, 2017
Q3 2017 -62.8 +60.9 +49.2% Jul 1, 2017 Sep 30, 2017
Q2 2017 -59.9 +54.6 +47.7% Apr 1, 2017 Jun 30, 2017
Q1 2017 -162 -125 -344% Jan 1, 2017 Mar 31, 2017
Q4 2016 -140 -57.4 -69.7% Oct 1, 2016 Dec 31, 2016
Q3 2016 -124 -21.6 -21.2% Jul 1, 2016 Sep 30, 2016
Q2 2016 -115 +9.96 +8% Apr 1, 2016 Jun 30, 2016
Q1 2016 -36.4 +106 +74.5% Jan 1, 2016 Mar 31, 2016
Q4 2015 -82.4 -22.8 -38.1% Oct 1, 2015 Dec 31, 2015
Q3 2015 -102 -51.5 -102% Jul 1, 2015 Sep 30, 2015
Q2 2015 -124 -50.1 -67.3% Apr 1, 2015 Jun 30, 2015
Q1 2015 -143 -39.8 -38.7% Jan 1, 2015 Mar 31, 2015
Q4 2014 -59.7 +49 +45.1% Oct 1, 2014 Dec 31, 2014
Q3 2014 -50.6 +90.9 +64.2% Jul 1, 2014 Sep 30, 2014
Q2 2014 -74.4 +32.4 +30.3% Apr 1, 2014 Jun 30, 2014
Q1 2014 -103 -12.7 -14.1% Jan 1, 2014 Mar 31, 2014
Q4 2013 -109 -23.7 -27.8% Oct 1, 2013 Dec 31, 2013
Q3 2013 -141 -75.1 -113% Jul 1, 2013 Sep 30, 2013
Q2 2013 -107 -56.4 -112% Apr 1, 2013 Jun 30, 2013
Q1 2013 -90.2 -51.1 -131% Jan 1, 2013 Mar 31, 2013
Q4 2012 -85 Oct 1, 2012 Dec 31, 2012
Q3 2012 -66.4 Jul 1, 2012 Sep 30, 2012
Q2 2012 -50.3 Apr 1, 2012 Jun 30, 2012
Q1 2012 -39.1 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.